Literature DB >> 17083102

LRRK2 G2019S founder haplotype in the Chinese population.

Eng-King Tan1, Lisa Skipper, Louis Tan, Jian-Jun Liu.   

Abstract

The G2019S mutation in the LRRK2 (leucine-rich repeat kinase) gene appears very rarely in the Chinese population. Among Chinese subjects who were non-G2019S carriers, we demonstrated the frequency of the LRRK2 G2019S founder haplotype (T-254-A-G-A-154) in Parkinson's disease and controls to be 33% and 30%. This rate is similar to the frequency in European noncarriers, indirectly supporting the association of this haplotype with G2019S carriers. The haplotype is likely to be more ancient than the G2019S mutation because it is also found in a population with a very low carrier rate. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17083102     DOI: 10.1002/mds.21206

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  1 in total

Review 1.  Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.

Authors:  Jeffrey Kim; Marcel M Daadi
Journal:  Brain Res       Date:  2019-07-19       Impact factor: 3.252

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.